GM-CSF

Summary

Gene Symbol: GM-CSF
Description: colony stimulating factor 2 (granulocyte-macrophage)
Alias: GMCSF, CSF, colony-stimulating factor, granulocyte-macrophage colony stimulating factor, granulocyte-macrophage colony-stimulating factor, molgramostin, sargramostim
Species: human

Top Publications

  1. ncbi A conserved insulator that recruits CTCF and cohesin exists between the closely related but divergently regulated interleukin-3 and granulocyte-macrophage colony-stimulating factor genes
    Sarion R Bowers
    Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, St James s University Hospital, Leeds LS9 7TF, United Kingdom
    Mol Cell Biol 29:1682-93. 2009
  2. ncbi Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization
    Brett V Johnson
    Molecular Medicine Unit, Department of Medicine, St James s University Hospital, University of Leeds, Leeds, England
    Mol Cell Biol 24:7914-30. 2004
  3. ncbi [Prevention and treatment of febrile neutropenia]
    F Montemurro
    Dipartimento di Scienze Biomediche ed Oncologia Umana, , Italy
    Tumori 83:S15-9. 1997
  4. ncbi The use of colony-stimulating factors as bone marrow support for systemic anticancer chemotherapy
    E Reed
    Gynecologic Oncology Section, National Cancer Institute, Bethesda, MD 20892
    J Natl Med Assoc 86:459-64. 1994
  5. ncbi Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
    J W Simons
    Johns Hopkins Oncology Center, Brady Urological Institute, and Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Cancer Res 59:5160-8. 1999
  6. ncbi Inflammatory cytokines in the herniated disc of the lumbar spine
    H Takahashi
    First Department of Orthopaedic Surgery, Tokyo, Japan
    Spine (Phila Pa 1976) 21:218-24. 1996
  7. ncbi Augmentation of host resistance to Listeria monocytogenes infection by a traditional Chinese medicine, ren-shen-yang-rong-tang (Japanese name: ninjin-youei-to)
    K Yonekura
    Traditional Chinese Medicine Research Laboratories, Kanebo Co. Ltd, Osaka, Japan
    Immunopharmacol Immunotoxicol 14:165-90. 1992
  8. ncbi Effect of recombinant human granulocyte/macrophage colony-stimulating factor on neutrophil superoxide production
    R M Schultz
    Lilly Research Laboratories, Indianapolis, IN 46285
    Immunopharmacol Immunotoxicol 13:183-98. 1991
  9. ncbi Characterization of the isoforms of PIXY321, a granulocyte-macrophage-colony stimulating factor-interleukin-3 fusion protein, separated by preparative isoelectric focusing on immobilized pH gradients
    A Balland
    Immunex Corp, Seattle, WA 98101, USA
    J Chromatogr A 846:143-56. 1999
  10. ncbi Functional changes in THP-1 human monocytic cells after stimulation with lipopolysaccharide of oral microorganisms and granulocyte macrophage colony stimulating factor
    A A Baqui
    Department of Oral Medicine, Dental School, University of Maryland, Baltimore 21201, USA
    Immunopharmacol Immunotoxicol 20:493-518. 1998

Research Grants

Detail Information

Publications184 found, 100 shown here

  1. ncbi A conserved insulator that recruits CTCF and cohesin exists between the closely related but divergently regulated interleukin-3 and granulocyte-macrophage colony-stimulating factor genes
    Sarion R Bowers
    Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, St James s University Hospital, Leeds LS9 7TF, United Kingdom
    Mol Cell Biol 29:1682-93. 2009
    The human interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating-factor (GM-CSF, or CSF2) gene cluster arose by duplication of an ancestral gene...
  2. ncbi Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization
    Brett V Johnson
    Molecular Medicine Unit, Department of Medicine, St James s University Hospital, University of Leeds, Leeds, England
    Mol Cell Biol 24:7914-30. 2004
    The human granulocyte-macrophage colony-stimulating factor (GM-CSF) gene is activated by an NFAT-dependent enhancer forming an inducible DNase I hypersensitive (DH) site...
  3. ncbi [Prevention and treatment of febrile neutropenia]
    F Montemurro
    Dipartimento di Scienze Biomediche ed Oncologia Umana, , Italy
    Tumori 83:S15-9. 1997
    ..Under these conditions, the administration of granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) accelerates neutrophil recovery and shortens the ..
  4. ncbi The use of colony-stimulating factors as bone marrow support for systemic anticancer chemotherapy
    E Reed
    Gynecologic Oncology Section, National Cancer Institute, Bethesda, MD 20892
    J Natl Med Assoc 86:459-64. 1994
    ..Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are two such compounds that have been approved by ..
  5. ncbi Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
    J W Simons
    Johns Hopkins Oncology Center, Brady Urological Institute, and Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Cancer Res 59:5160-8. 1999
    Vaccination with irradiated granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting gene-transduced cancer vaccines induces tumoricidal immune responses...
  6. ncbi Inflammatory cytokines in the herniated disc of the lumbar spine
    H Takahashi
    First Department of Orthopaedic Surgery, Tokyo, Japan
    Spine (Phila Pa 1976) 21:218-24. 1996
    ..alpha, interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and granulocyte-macrophage colony stimulating factor, which were detectable...
  7. ncbi Augmentation of host resistance to Listeria monocytogenes infection by a traditional Chinese medicine, ren-shen-yang-rong-tang (Japanese name: ninjin-youei-to)
    K Yonekura
    Traditional Chinese Medicine Research Laboratories, Kanebo Co. Ltd, Osaka, Japan
    Immunopharmacol Immunotoxicol 14:165-90. 1992
    ..After ip injection of NIN, interleukin-1 (IL-1), IL-6 and granulocyte macrophage-colony stimulating factor (GM-CSF) became detectable in the serum or peritoneal cavity...
  8. ncbi Effect of recombinant human granulocyte/macrophage colony-stimulating factor on neutrophil superoxide production
    R M Schultz
    Lilly Research Laboratories, Indianapolis, IN 46285
    Immunopharmacol Immunotoxicol 13:183-98. 1991
    Recombinant human granulocyte/macrophage colony-stimulating factor (GM-CSF) induced significant superoxide production in human neutrophils within 30 minutes after addition of stimulus and the response was complete within 2 hr...
  9. ncbi Characterization of the isoforms of PIXY321, a granulocyte-macrophage-colony stimulating factor-interleukin-3 fusion protein, separated by preparative isoelectric focusing on immobilized pH gradients
    A Balland
    Immunex Corp, Seattle, WA 98101, USA
    J Chromatogr A 846:143-56. 1999
    ..characterization of the isoforms of PIXY321, a genetically engineered fusion of granulocyte-macrophage-colony stimulating factor and interleukin-3 expressed in yeast...
  10. ncbi Functional changes in THP-1 human monocytic cells after stimulation with lipopolysaccharide of oral microorganisms and granulocyte macrophage colony stimulating factor
    A A Baqui
    Department of Oral Medicine, Dental School, University of Maryland, Baltimore 21201, USA
    Immunopharmacol Immunotoxicol 20:493-518. 1998
    A human THP-1 monocyte cell line culture system has been utilized to observe the effect of granulocyte macrophage colony stimulating factor (GM-CSF) supplementation with lipopolysaccharide (LPS) of oral microorganisms to stimulate ..
  11. ncbi [In vitro assay method for augmention of anti-Candida activity of murine bone marrow cells by cytokines]
    S Morofuji
    Department of Microbiology and Immunology, Teikyo University School of Medicine
    Kansenshogaku Zasshi 75:326-32. 2001
    ..to develop a sensitive assay method for evaluation of immunomodulating candidates including granulocyte-colony stimulating factor (G-CSF) which may augment host defense function against opportunistic infections...
  12. ncbi Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12
    K Ito
    Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, United Kingdom
    Mol Cell Biol 20:6891-903. 2000
    ..of dexamethasone (10(-10) M) repress IL-1beta-stimulated granulocyte-macrophage colony-stimulating factor (GM-CSF) expression and fail to stimulate secretory leukocyte proteinase inhibitor expression...
  13. ncbi Purification of recombinant human granulocyte-macrophage colony-stimulating factor from the inclusion bodies produced by transformed Escherichia coli cells
    M Belew
    Pharmacia Bioprocess Technology, Uppsala, Sweden
    J Chromatogr A 679:67-83. 1994
    Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF), produced as inclusion bodies in genetically transformed Escherichia coli cells was purified to homogeneity by a three-step chromatographic procedure involving ..
  14. ncbi Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils
    P P McDonald
    Centre de Recherche en Inflammation, Immunologie et Rhumatologie, Institut de recherche du CHUL, Ste Foy, , Canada
    Br J Pharmacol 111:852-60. 1994
    ..3. In recombinant human (rh) granulocyte-macrophage colony-stimulating factor (GM-CSF)-primed neutrophils, LT synthesis in response to chemoattractants (fMet-Leu-Phe or rhC5a) was also significantly ..
  15. ncbi Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience
    R T Costello
    INSERM U119, , Marseille, France
    Acta Oncol 32:403-8. 1993
    ..Recent therapeutic trials with granulocyte-macrophage colony-stimulating factors (GM-CSF) in association with chemotherapy, bone marrow transplantation and leukemia treatment are reviewed...
  16. ncbi p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex
    K Ito
    Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, Dovehouse St, London SW3 6LY, United Kingdom
    J Biol Chem 276:30208-15. 2001
    ..These data also suggest that pharmacological manipulation of specific histone acetylation status is a potentially useful approach for the treatment of inflammatory diseases...
  17. ncbi In vitro effects of recombinant human granulocyte-macrophage colony-stimulating factor (RhGM-CSF) on polymorphonuclear cell (PMN) and monocyte (MO) functional capacities in ovarian cancer patients versus human volunteers
    M Altamura
    Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari Medical School, Italy
    Immunopharmacol Immunotoxicol 19:437-49. 1997
    ..normal donors were in vitro pretreated with different concentrations (25, 50 and 100 IU, respectively) of rhGM-CSF. Phagocytosis and killing of PMN and MO as well as PMN polarization were evaluated in cancer patients before ..
  18. ncbi Effect of Withania somnifera on cytokine production in normal and cyclophosphamide treated mice
    L Davis
    Amala Cancer Research Centre, Kerala, India
    Immunopharmacol Immunotoxicol 21:695-703. 1999
    ..87 pg/ml), Interleukin-2 (IL-2) (14.16 pg/ml) and Granulocyte macrophage colony stimulating factor (GM-CSF) (49.22 pg/ml) in normal Balb/c mice...
  19. ncbi Recombinant human granulocyte-macrophage colony-stimulating factor in acquired or chemotherapy-induced neutropenia. An open clinical trial
    D Piguet
    Service d'oncologie, , , Switzerland
    Acta Oncol 33:639-43. 1994
    ..evaluated the efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients with established neutropenia, considering as the main endpoint the clinical benefit to the patients ..
  20. ncbi Diesel exhaust particles enhance airway responsiveness following allergen exposure in mice
    H Takano
    Research Team for Health Effects of Air Pollutants, National Institute for Environmental Studies, Ibaraki, Japan
    Immunopharmacol Immunotoxicol 20:329-36. 1998
    ..eosinophilic airway inflammation, local expression of interleukin-5 and granulocyte macrophage-colony stimulating factor, and allergen-specific production of IgE and IgG in mice...
  21. ncbi Effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hematologic toxicity induced by high-dose chemotherapy in patients with metastatic breast cancer
    F Hansen
    Department of Oncology, Herlev University Hospital, Denmark
    Acta Oncol 34:919-24. 1995
    ..130 mg/m2, both every 3 weeks) as first or second line chemotherapy were randomized in a prospective study to GM-CSF 5 micrograms/kg per day (n = 11) or control (n = 9)...
  22. ncbi Analysis of Egr-1 protein induction in murine peritoneal macrophages treated with granulocyte-macrophage colony-stimulating factor
    C Li
    Department of Internal Medicine, Yale University School of Medicine, West Haven, Connecticut, USA
    Yale J Biol Med 67:269-76. 1994
    ..Since granulocyte-macrophage colony-stimulating factor (GM-CSF) induces macrophage proliferation as well as the transcription of Egr-1 mRNA, we characterized the induction of Egr-..
  23. ncbi Influence of bestatin on production of granulocyte-macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro
    S Okamura
    First Department of Internal Medicine, Faculty of Medicine, Kyushu University Hospital, Fukuoka, Japan
    Acta Oncol 29:795-7. 1990
    ..To elucidate the mechanisms of this effect, the levels of colony-stimulating factor (CSF) in culture supernatant of 1 x 10(6)/ml peripheral blood mononuclear cells (PBMC) cocultured with various ..
  24. ncbi Bleomycin and FK 565 enhance the release of GM-CSF from LPS-stimulated BALB/c peritoneal macrophages
    B A Blaney
    Immunology Department, Strathclyde University, Glasgow
    Immunopharmacol Immunotoxicol 17:451-69. 1995
    ..in vitro effects on the release of the haemopoietic cytokine Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) from LPS stimulated BALB/c adherent peritoneal macrophages...
  25. ncbi Microemulsion electrokinetic chromatography of proteins
    G H Zhou
    Department of Chemistry, Tsinghua University, Beijing, China
    J Chromatogr A 853:277-84. 1999
    ..and successfully applied to the assay of genetically engineering pharmaceuticals, recombinant human granulocyte macrophage colony stimulating factor injection and recombinant human granulocyte colony stimulating factor injection.
  26. ncbi Successful treatment of herpes simplex virus (HSV) recurrent genital infection with recombinant human (rh) granulocyte-macrophage colony stimulating factor (GM-CSF): a case report
    M Altamura
    Cattedra di Immunologia and Clinica Ostetrica e Ginecologica II, , , Italy
    Immunopharmacol Immunotoxicol 19:425-36. 1997
    In the present work, we describe the treatment with rhGM-CSF of a woman affected by HSV recurrent genital infection and not responsive to specific antiviral therapy...
  27. ncbi Effects of Pseudostellaria heterophylla on proliferation and differentiation of murine bone marrow cells
    C K Wong
    Department of Biochemistry, Chinese University of Hong Kong, Shatin, New Territories
    Immunopharmacol Immunotoxicol 16:71-84. 1994
    ..Autocrine or paracrine stimulation of granulocyte-macrophage colony stimulating factor was likely to underly the induction of differentiation...
  28. ncbi Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes
    L M Budel
    Dr Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Blood 75:1439-45. 1990
    Granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) control the proliferation of human acute myeloid leukemia (AML) cells in vitro...
  29. ncbi Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins
    Y Kanakura
    Dana Farber Cancer Institute, Boston, MA 02115
    Blood 76:706-15. 1990
    Human granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) exert multiple effects on the proliferation, differentiation, and function of myeloid lineage cells through their interaction with specific cell-..
  30. ncbi The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain
    Y Zhao
    Division of Hematology Oncology, Veterans Administration Medical Center, Birmingham, Alabama 35294, USA
    J Biol Chem 270:13814-8. 1995
    The binding of granulocyte-macrophage colony stimulating factor (GM-CSF) to its receptor stimulates JAK2 protein kinase activation, protein phosphorylation, and JAK2 association with the beta c chain of the GM-CSF receptor...
  31. ncbi Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex
    J D Levine
    Department of Medicine, New England Deaconess Hospital, Harvard Medical School, Boston, MA
    Blood 78:3148-54. 1991
    To evaluate the effect of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) on patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) who were intolerant to zidovudine because of ..
  32. ncbi Signaling functions of the tyrosine residues in the betac chain of the granulocyte-macrophage colony-stimulating factor receptor
    K Okuda
    Division of Hematologic Malignancies, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
    Blood 90:4759-66. 1997
    The granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor (GMR) is a heterodimeric receptor expressed by myeloid lineage cells...
  33. ncbi Granulocyte-macrophage colony-stimulating factor amplification of interleukin-1beta and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms
    A A Baqui
    Department of Oral Medicine, Dental School, University of Maryland, Baltimore 21201, USA
    Clin Diagn Lab Immunol 5:341-7. 1998
    Cytokines, including granulocyte-macrophage colony-stimulating factor (GM-CSF), are used to assist in bone marrow recovery during cancer chemotherapy...
  34. ncbi Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF
    F C Stomski
    The Cytokine Receptor Laboratory, The Hanson Centre for Cancer Research and Institute of Medical and Veterinary Science, Adelaide, Australia
    Blood 94:1933-42. 1999
    The common beta chain (beta(c)) of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors is the major signaling subunit of these receptors coupling ligand binding to multiple biological ..
  35. ncbi Purified murine granulocyte/macrophage progenitor cells express a high-affinity receptor for recombinant murine granulocyte/macrophage colony-stimulating factor
    D E Williams
    Department of Medicine Hematology Oncology, Indiana University School of Medicine, Indianapolis 46223
    Proc Natl Acad Sci U S A 85:487-91. 1988
    Purified recombinant murine granulocyte/macrophage colony-stimulating factor (GM-CSF) was labeled with 125I and used to examine the GM-CSF receptor on unfractionated normal murine bone marrow cells, casein-induced peritoneal exudate ..
  36. ncbi Expression and function of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit
    P T Jubinsky
    Division of Pediatric Hematology and Oncology, Children s Hospital, Boston, MA
    Blood 84:4174-85. 1994
    To determine the expression and function of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha chain (GMR alpha) during hematopoiesis and on leukemic cells, monoclonal antibodies were raised by immunizing mice ..
  37. ncbi Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibition
    N J Donato
    Department of Bioimmunotherapy, M D Anderson Cancer Center, University of Texas, Houston 77030, USA
    Blood 97:2846-53. 2001
    ..Expression of bcr-abl in interleukin-3 (IL-3)/granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent Mo7e cells (MBA) resulted in growth factor independence, constitutive activation of Stat-5 ..
  38. ncbi Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure
    U Dirksen
    Department of Pediatric Hematology Oncology, Children s Hospital Medical Center, Heinrich Heine University, Dusseldorf, Germany
    Blood 92:1097-103. 1998
    Deficiency of the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin-3 (IL-3)/IL-5 receptors common beta chain (betac) is a cause of fatal respiratory failure...
  39. ncbi Clinical safety of a viral vector based prostate cancer vaccine strategy
    Philip M Arlen
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Urol 178:1515-20. 2007
    ....
  40. ncbi Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor
    M E Rothenberg
    Department of Medicine, Harvard Medical School, Boston, Massachusetts
    J Biol Chem 263:13901-8. 1988
    ..of recombinant human interleukin (IL) 3, mouse IL 5, or recombinant human granulocyte/macrophage colony stimulating factor (GM-CSF) and then were radiolabeled with [35S]sulfate to characterize their cell-associated ..
  41. ncbi Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis
    J F Seymour
    Ludwig Institute for Cancer Research, Parkville, Australia
    Blood 92:2657-67. 1998
    ..Gene-targeted mice lacking the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF) or the signal-transducing beta-common chain of the GM-CSF receptor have impaired surfactant clearance and ..
  42. ncbi Effect of granulocyte-macrophage colony-stimulating factor deficiency on ovarian follicular cell function
    R B Gilchrist
    The Reproductive Medicine Unit, Department of Obstetrics and Gynaecology, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia
    J Reprod Fertil 120:283-92. 2000
    Granulocyte-macrophage colony-stimulating factor (GM-CSF), a cytokine secreted by lymphohaemopoietic and other cell lineages, is known to influence ovarian cyclicity and embryo development...
  43. ncbi Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer
    C I Rivas
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Blood 91:1037-43. 1998
    We studied the expression and function of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor in the human prostate carcinoma cell line LNCaP and looked for its presence in normal and neoplastic human prostatic tissue...
  44. ncbi Granulocyte-macrophage colony-stimulating factor promotes glucose transport and blastomere viability in murine preimplantation embryos
    S A Robertson
    Department of Obstetrics and Gynaecology, University of Adelaide, Adelaide 5005, Australia
    Biol Reprod 64:1206-15. 2001
    Granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion from epithelial cells lining the female reproductive tract is induced during early pregnancy by ovarian steroid hormones and constituents of seminal plasma...
  45. ncbi Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit mediate activation of Jak/Stat signaling and differentiation
    M B Lilly
    Department of Medicine and the Center for Molecular Biology and Gene Therapy, Loma Linda University, Loma Linda, CA 92354, USA
    Blood 97:1662-70. 2001
    The alpha subunit of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor has several isoforms that result from alternative splicing events...
  46. ncbi 217 effects of porcine granulocyte-macrophage colony-stimulating factor on porcine in vitro-fertilized embryos
    S S Kwak
    Laboratory of Veterinary Embryology and Biotechnology VETEMBIO, College of Veterinary Medicine, Chungbuk National University, Cheongju 361 763, Republic of Korea
    Reprod Fertil Dev 23:207-8. 2011
    The cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in the female reproductive tract and is one of the regulatory molecules that mediate maternal effects on the growth and development of pre-implantation ..
  47. ncbi Granulocyte-macrophage colony-stimulating factor ensures macrophage survival and generation of the superoxide anion: a study using a monocytic-differentiated HL60 subline
    M Ujihara
    Department of Medicine, Institute of Clinical Endocrinology, Tokyo, Japan
    Free Radic Biol Med 31:1396-404. 2001
    ..to atherosclerotic lesions, and current evidence suggests that granulocyte-macrophage colony-stimulating factor (GM-CSF) is one of these constituents...
  48. ncbi Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity
    Wenli Zhao
    Department of Hematology, Shaanxi Provincial People s Hospital, Xi an 710068, China or
    Chin Med J (Engl) 115:1296-300. 2002
    ..To establish a serum-free culture system of dendritic cells (DCs) from chronic myeloid leukemia (CML) cells so that DCs vaccine may be applied to the adoptive immunotherapy of CML in the near future...
  49. ncbi Neurotrophic action of interleukin 3 and granulocyte-macrophage colony-stimulating factor on murine sympathetic neurons
    Y Kannan
    Department of Veterinary Physiology, Graduate School of Agriculture and Biological Sciences, Osaka Prefecture University, Sakai, Japan
    Neuroimmunomodulation 8:132-41. 2000
    ..We investigated neurotrophic effects of interleukin 3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on cultured sympathetic neurons obtained from mouse superior cervical ganglia...
  50. ncbi Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor
    S Pastore
    Laboratory of Immunology, Istituto Dermopatico dell Immacolata, IRCCS, Rome, Italy
    J Invest Dermatol 115:1134-43. 2000
    ..J Invest Dermatol 115:1134-1143 2000..
  51. ncbi Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation
    Lysann Hesske
    Clinical Immunology, University Hospital of Zurich, Switzerland
    Brain 133:1637-54. 2010
    ....
  52. ncbi Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro
    Marja Leena Kylanpaa
    Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
    Pancreas 31:23-7. 2005
    ..in patients with severe AP and to determine whether treatment of blood samples with granulocyte-macrophage colony-stimulating factor (GM-CSF) and/or interferon-gamma (IFN-gamma) corrected the functional defects of monocytes in vitro.
  53. ncbi Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor
    T Kitamura
    Department of Molecular Biology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304
    Proc Natl Acad Sci U S A 88:5082-6. 1991
    The high-affinity receptor for human granulocyte/macrophage colony-stimulating factor (hGM-CSF) is composed of two subunits, alpha and beta...
  54. ncbi Ovarian immune cells express granulocyte-macrophage colony-stimulating factor (GM-CSF) during follicular growth and luteinization in gonadotropin-primed immature rodents
    K Tamura
    Department of Pharmacology, Tokyo University of Pharmacy and Life Science, Japan
    Mol Cell Endocrinol 142:153-63. 1998
    To obtain clues as to whether granulocyte-macrophage colony-stimulating factor (GM-CSF) is related to ovarian physiology, the sites, the gene expression and the production of GM-CSF in the ovary during follicular development and ..
  55. ncbi Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury
    Yoon Ha
    Departments of Neurosurgery and Physiology, Inha University College of Medicine, Inchon, Korea
    J Neurosurg Spine 2:55-61. 2005
    Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent hemopoietic cytokine that stimulates stem cell proliferation in the bone marrow and inhibits apoptotic cell death in leukocytes...
  56. ncbi Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation
    C Agostini
    Padua University School of Medicine, Department of Clinical Medicine, Italy
    J Immunol 149:3379-85. 1992
    In this paper, the release of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the lung of patients with HIV-1 infection was evaluated...
  57. ncbi Granulocyte/macrophage-colony-stimulating factor augments lymphokine-activated killer activity from lymphocytes via macrophages in lung cancer patients
    K Takahashi
    The Second Department of Surgery, School of Medicine, The University of Tokushima, Japan
    Cancer Immunol Immunother 49:537-43. 2000
    Therapies with granulocyte/macrophage-colony-stimulating factor (GM-CSF) and interleukin(IL)-2 are designed to activate macrophages and lymphocytes...
  58. ncbi Does granulocyte-macrophage colony-stimulating factor prevent bacterial translocation in rats with surgical trauma and obstructive jaundice?
    Ali E Demirbag
    Department of Gastrointestinal Surgery, Türkiye Yüksek Ihtisas Post Graduate Research and Teaching Hospital, Ankara, Turkey
    Turk J Gastroenterol 20:31-40. 2009
    ..The aim of this study was to prevent translocation and to increase Kupffer cell incidence by using granulocytemacrophage colony-stimulating factor in rats with surgical trauma and obstructive jaundice...
  59. ncbi Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases
    H Muller
    Department of Surgical Oncology, Carl von Hess Hospital, D 97762 Hammelburg, Germany
    Eur J Surg Oncol 27:652-61. 2001
    ..We compared two prospective trials of intra-arterial cytokine/chemotherapeutic infusion plus chemoembolization in the treatment of inoperable colorectal liver metastases...
  60. ncbi Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma
    Loredana Postiglione
    Dipartimento di Biologia e Patologia Cellulare e Molecolare, Universita degli Studi Federico II, Naples, Italy
    J Rheumatol 32:656-64. 2005
    To investigate the in vitro effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on the deposition of extracellular matrix (ECM) in fibroblasts obtained from the skin of patients with systemic sclerosis (Ssc), compared ..
  61. ncbi Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing
    Eric Bernasconi
    Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland
    Inflamm Bowel Dis 16:428-41. 2010
    Granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy is effective in treating some Crohn's disease (CD) patients and protects mice from colitis induced by dextran sulfate sodium (DSS) administration...
  62. ncbi Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions
    R Nishinakamura
    DNAX Research Institute, Palo Alto, CA 94304 1104, USA
    Blood 88:2458-64. 1996
    Interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-5 are major hematopoietic cytokines produced by activated T cells and exhibit similar biologic activities by signaling through a common receptor ..
  63. ncbi Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF
    O N Koc
    Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
    J Clin Oncol 18:1824-30. 2000
    ..compared the number of progenitors mobilized into blood after granulocyte-macrophage colony-stimulating factor (GM-CSF) days 1 to 12 plus granulocyte colony-stimulating factor (G-CSF) days 7 to 12 (regimen G) with the number of ..
  64. ncbi Characterization of ovarian function in granulocyte-macrophage colony-stimulating factor-deficient mice
    M J Jasper
    Reproductive Medicine Unit, Department of Obstetrics and Gynaecology, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, South Australia 5011, Australia
    Biol Reprod 62:704-13. 2000
    ..of this study was to investigate the physiological role of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the ovary, utilizing mice genetically deficient in GM-CSF...
  65. ncbi Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction
    John T Parissis
    First Department of Cardiology, Amalia Fleming Hospital, Athens Greece
    Eur Cytokine Netw 15:139-44. 2004
    No in vivo data exist about the relationship of circulating granulocyte-macrophage colony stimulating factor (GM-CSF) and soluble adhesion molecules ICAM-1 and VCAM-1 (sICAM-1 and sVCAM-1) to the severity of acute myocardial infarction (..
  66. ncbi Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
    A Le Cesne
    Institut Gustave Roussy, Villejuif, London, United Kingdom
    J Clin Oncol 18:2676-84. 2000
    ..This randomized multicenter study was designed to compare the activity of a high-dose doxorubicin-containing chemotherapy regimen with a conventional standard-dose regimen in adult patients with advanced soft tissue sarcomas (ASTS)...
  67. ncbi Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia
    Arthur E Frankel
    Wake Forest University Baptist Medical Center, Winston Salem, North Carolina 27157, USA
    Clin Cancer Res 8:1004-13. 2002
    ..We tested the safety and efficacy of a diphtheria fusion protein [diphtheria toxin (DT)388 granulocyte-macrophage colony-stimulating factor (GMCSF)] directed against the GMCSF receptor that is strongly expressed by leukemic blasts.
  68. ncbi Murine nucleus pulposus-derived cells secrete interleukins-1-beta, -6, and -10 and granulocyte-macrophage colony-stimulating factor in cell culture
    N Rand
    Vanderbilt University Spine Center, Nashville, Tennessee 37232 2550, USA
    Spine (Phila Pa 1976) 22:2598-601; discussion 2602. 1997
    ..This finding supports the hypothesis that disc-derived cells are capable of initiating or amplifying an inflammatory process...
  69. ncbi Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study
    Kauko Saarilahti
    Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland
    Int J Radiat Oncol Biol Phys 54:479-85. 2002
    To compare granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwashes with sucralfate mouthwashes in the prevention of radiation-induced mucositis.
  70. ncbi Granulocyte-macrophage colony-stimulating factor increases L-arginine transport through the induction of CAT2 in bone marrow-derived macrophages
    Lorena Martin
    Department of Biochemistry and Molecular Biology, University of Barcelona, Avenida Diagonal 645, Barcelona E 08028, Spain
    Am J Physiol Cell Physiol 290:C1364-72. 2006
    ..The granulocyte macrophage colony-stimulating factor (GM-CSF), in addition to inducing proliferation and differentiation of macrophages, activates arginase I, but its action on ..
  71. ncbi Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor
    John H Edmonson
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 94:786-92. 2002
    ..This single-institution Phase II study describes an effort to control metastasis by the use of two cycles of chemotherapy as the initial preoperative treatment...
  72. ncbi Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin
    L L Miller
    Frederick Cancer Research and Development Center, Biological Response Modifiers Program, National Cancer Institute, Frederick, MD, USA
    Blood 93:3250-8. 1999
    ..The immunogenicity of this fusion protein provides a cautionary warning that clinical development of bioengineered human molecules requires thorough testing for immune neutralization...
  73. ncbi Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
    W G Nelson
    Johns Hopkins Oncology Center, Baltimore, MD 21231, USA
    Cancer Chemother Pharmacol 46:S67-72. 2000
    ..as vaccines, cancer cells engineered to secrete high levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) by gene transfer elicit potent anticancer immune responses in a variety of animal tumor models...
  74. ncbi Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor
    M Kalaycio
    Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Ohio 44195, USA
    Am J Clin Oncol 24:58-63. 2001
    ..population with perhaps less toxicity when combined with granulocyte-macrophage colony-stimulating factor (GM-CSF)...
  75. ncbi In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs
    P Mayer
    Sandoz Forschungsinstitut, Vienna, Austria
    Exp Hematol 18:1026-33. 1990
    Although it is well documented that human granulocyte-macrophage colony-stimulating factor (GM-CSF) controls the production and functional activity of human and nonhuman primate granulocytes and macrophages, relatively little is known ..
  76. ncbi Effect of thyroid hormones and other iodinated compounds on the transition of monocytes into veiled/dendritic cells: role of granulocyte-macrophage colony-stimulating factor, tumour-necrosis factor-alpha and interleukin-6
    P Mooij
    Department of Immunology, Erasmus University, Rotterdam, The Netherlands
    J Endocrinol 140:503-12. 1994
    ..induced by T3 and T4 was dependent on the production of granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor-alpha (TNF alpha) and interleukin-6 (IL-6) in the culture, since the addition of ..
  77. ncbi Binding properties and proliferative effects of human recombinant granulocyte-macrophage colony-stimulating factor in primary leukemia and lymphoma
    Y F Piao
    Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo
    Jpn J Cancer Res 80:887-94. 1989
    Binding of radiolabeled human granulocyte-macrophage colony-stimulating factor (GM-CSF) was studied with blast cells from eight patients with acute myeloblastic leukemia (AML), and neoplastic lymphoid cells from one patient with acute ..
  78. ncbi Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (
    O Bruserud
    Department of Medicine, Haukeland University Hospital and the University of Bergen, N 5021 Bergen, Norway
    Eur Cytokine Netw 12:231-8. 2001
    ..Firstly, serum levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF and Flt3-ligand (Flt3L) were examined in acute leukemia patients with treatment-induced cytopenia and ..
  79. ncbi Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice
    K Brasel
    Department of Immunobiology, Immunex Corporation, Seattle, WA 98101, USA
    Blood 90:3781-8. 1997
    ..human flt3 ligand (FL), alone and in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF ) or granulocyte colony-stimulating factor (G-CSF ), to mobilize colony forming cells (CFU) into the peripheral ..
  80. ncbi GM-CSF plays a key role in zymosan-stimulated human dendritic cells for activation of Th1 and Th17 cells
    Wen Chi Wei
    Agricultural Biotechnology Research Center, Academia Sinica, Taiwan, ROC
    Cytokine 55:79-89. 2011
    ..zymosan on the expression of several key cytokines, including granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukins (IL-1?, IL-1? and IL-12 p70) were quite distinct from the effects of LPS...
  81. ncbi Sargramostim for active Crohn's disease
    Joshua R Korzenik
    Inflammatory Bowel Disease Center, Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    N Engl J Med 352:2193-201. 2005
    b>Sargramostim, granulocyte-macrophage colony-stimulating factor, a hematopoietic growth factor, stimulates cells of the intestinal innate immune system. Preliminary studies suggest sargramostim may have activity in Crohn's disease...
  82. ncbi GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes
    Münci Yağcı
    Department of Hematology, Gazi Medical School, Birlik mah, 18 sok 5 5, Ankara, Turkey
    Leuk Res 29:735-8. 2005
    ..In this study, we examined the influence of granulocyte macrophage-colony stimulating factor (GM-CSF) on the expression level of CD20 antigen and percent of cells expressing CD20 antigen on B-CLL ..
  83. ncbi Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock
    Joerg C Schefold
    Department of Nephrology and Intensive Care Medicine, Charite University Medicine, Campus Virchow, Berlin, Germany
    Scand J Infect Dis 42:164-71. 2010
    ..We investigated whether immunostimulatory treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF) influences IDO activity and tryptophan metabolism in sepsis...
  84. ncbi Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine
    Xianzheng Zhou
    Division of Immunology and Hematopoiesis, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
    Cancer Res 65:1079-88. 2005
    ....
  85. ncbi Subcutaneous granulocyte-macrophage colony-stimulating factor in mucositis induced by an adjuvant 5-fluorouracil plus leucovorin regimen. A phase II study and review of the literature
    Antonio Rossi
    UO Oncologia Medica, Azienda Ospedaliera San G Moscati, Avellino, Italy
    Oncology 64:353-60. 2003
    To test the activity of subcutaneous granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in patients with colorectal cancer treated with adjuvant 5-fluorouracil (5-FU) plus leucovorin (LV) and suffering from mucositis.
  86. ncbi PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor
    Tracey L Bonfield
    Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195 5038, USA
    Am J Physiol Lung Cell Mol Physiol 285:L1132-6. 2003
    ..In vitro studies demonstrate that exogenous GMCSF treatment upregulated PU.1 and M-CSFR gene expression in PAP alveolar macrophages...
  87. ncbi Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor
    Tara M C Hornell
    Department of Pediatrics, School of Medicine, Stanford University, CCSR Room 2120, 269 Campus Drive, Stanford, CA 94305, USA
    J Immunol 171:2374-83. 2003
    GM-CSF stimulates the growth and differentiation of hematopoietic progenitors and also affects mature cell function...
  88. ncbi Impact of long-acting growth factors on practice dynamics and patient satisfaction
    Roy A Beveridge
    Inova Fairfax Hospital, Fairfax Northern Virginia Hematology Oncology, Fairfax, VA 22031, USA
    Pharmacotherapy 23:101S-109S. 2003
    To quantify time expended, patient satisfaction, and econometrics associated with short-acting (sargramostim, epoetin alfa) and long-acting (darbepoetin alfa, pegfilgrastim) growth factors.
  89. ncbi Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization
    Bernhard Braun
    Department of Gastroenterology, Hospital Darmstadt, Heidelberg, Germany
    J Neurooncol 68:131-40. 2004
    The hematopoietic growth factors granulocyte- and granulocyte-macrophage colony stimulating factor (G-CSF and GM-CSF) are nowadays widely used in routine cancer therapies as potent factors to control radiation and chemotherapy induced ..
  90. ncbi Consequences of conceptus exposure to colony-stimulating factor 2 on survival, elongation, interferon-? secretion, and gene expression
    Barbara Loureiro
    Department of Animal Sciences and DH Barron Reproductive and Perinatal Biology Research Program, University of Florida, PO Box 110910, Gainesville, Florida 32611 0910, USA
    Reproduction 141:617-24. 2011
    ..Results suggest that the increase in calving rate caused by CSF2 treatment involves, in part, more extensive development of extraembryonic membranes and capacity of the conceptus to secrete IFNT2 at day 15 of pregnancy...
  91. ncbi GM-CSF is an essential regulator of T cell activation competence in uterine dendritic cells during early pregnancy in mice
    Lachlan M Moldenhauer
    Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, Australia
    J Immunol 185:7085-96. 2010
    ..GM-CSF (CSF2), a known regulator of DCs, is synthesized by uterine epithelial cells during induction of tolerance in early ..
  92. ncbi GM-CSF cannot substitute for M-CSF in human osteoclastogenesis
    Jason M Hodge
    Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Victoria 3220, Australia
    Biochem Biophys Res Commun 321:7-12. 2004
    Osteopetrotic mice lacking functional M-CSF recover with ageing, suggesting alternate osteoclastogenesis pathways exist. One alternative is GM-CSF, treatment with which improves the osteopetrosis...
  93. ncbi A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivo
    Patrick Williams
    Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Mol Ther 18:1293-301. 2010
    We hypothesized that fusing granulocyte-macrophage colony-stimulation factor (GMCSF) and interleukin (IL)-21 as a single bifunctional cytokine (hereafter GIFT-21) would lead to synergistic anticancer immune effects because of their ..
  94. ncbi Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster
    J T Forton
    The Wellcome Trust Centre for Human Genetics, University of Oxford, UK
    Thorax 64:345-52. 2009
    ..A recent twin study estimated a heritable contribution of 22% to RSV bronchiolitis. Genetic epidemiology provides a new approach to identifying important immune determinants of disease severity...
  95. ncbi Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival
    J Mullol
    IDIBAPS, Rhinology Unit, ENT Department, Hospital Clinic, Deparmtent of Medicine, Universitat de Barcelona, Barcelona, Catalonia, Spain
    Clin Exp Allergy 36:52-8. 2006
    ..Second-generation antihistamines are H(1) receptor antagonists and may have additional anti-inflammatory effects...
  96. ncbi Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung?
    Koh Nakata
    Bioscience and Medical Research Center, Niigata University Medical and Dental Hospital, Asahimachi Dohri, Niigata, Japan
    Respirology 11:S65-9. 2006
    ..IPAP), the authors found that the autoantibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) was consistently present in both sera and the lung tissue...
  97. ncbi Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study
    Guillaume Cartron
    Centre hospitalier universitaire CHU, Service d Hématologie et d Oncologie Médicale, Montpellier, France
    J Clin Oncol 26:2725-31. 2008
    We hypothesized that granulocyte-macrophage colony-stimulating factor (GM-CSF) could potentiate the clinical activity of rituximab given its individual and cooperative effects on Fc gamma RIIa- and Fc gamma RIIIa-expressing cells...
  98. ncbi Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5
    Takafumi Yamaguchi
    Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi, Gunma, Japan
    Immunol Lett 118:88-95. 2008
    ..the effector functions of human eosinophils stimulated by granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-5...
  99. ncbi Increased transcription of cytokine genes in human lung epithelial cells through activation of a TRPM8 variant by cold temperatures
    Ashwini S Sabnis
    Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah 84112 5820, USA
    Am J Physiol Lung Cell Mol Physiol 295:L194-200. 2008
    ..genes, including IL-1alpha, -1beta, -4, -6, -8, and -13, granulocyte-macrophage colony-stimulating factor (GM-CSF), and TNF-alpha...
  100. ncbi Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis
    Satheesh K Sainathan
    Division of Gastroenterology, Washington University School of Medicine, St Louis, Missouri, USA
    Inflamm Bowel Dis 14:88-99. 2008
    b>Sargramostim, granulocyte macrophage colony-stimulating factor (GM-CSF), a hematopoietic growth factor, stimulates cells of the intestinal innate immune system...
  101. ncbi Production of transgenic recloned piglets harboring the human granulocyte-macrophage colony stimulating factor (hGM-CSF) gene from porcine fetal fibroblasts by nuclear transfer
    K W Park
    MGEN, Inc, 1101 World Meridian Venture Center, 60 24 Gasan Dong, Guemchun Gu, Seoul 153 781, Republic of Korea
    Theriogenology 70:1431-8. 2008
    ..NT) to develop transgenic female pigs harboring goat beta-casein promoter/human granulocyte-macrophage colony stimulating factor (hGM-CSF)...

Research Grants102 found, 100 shown here

  1. GM-CSF THERAPY FOR ALVEOLAR PROTEINOSIS
    Mary Jane Thomassen; Fiscal Year: 2003
    ..Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) deficient mice develop a PAP like syndrome which is corrected by exogenous GM-CSF, suggesting a ..
  2. ACTIVATED MUTANTS AS PROBES OF GM-CSF RECEPTOR FUNCTION
    RICHARD D ANDREA; Fiscal Year: 2003
    This project aims to investigate the function of the receptors for granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and interleukin-5 (IL-5)...
  3. ACTIVATED MUTANTS AS PROBES OF GM/CSF RECEPTOR FUNCTION
    RICHARD D ANDREA; Fiscal Year: 2000
    ..abstract) This project aims to investigate the function of the receptors for granulocyte-macrophage colony stimulating factor (GM-CSF), Interleukin-3 (IL-3) and Interleukin-5 (IL-5)...
  4. GROWTH FACTORS IN NORMAL AND NEOPLASTIC HEMATOPOIESIS
    Kenneth Kaushansky; Fiscal Year: 1993
    ..ligand or mast cell growth factor), interleukin (IL-) 3 and granulocyte-macrophage colony-stimulating factor (GM-CSF)...
  5. Roles of GM-CSF in Energy and Glucose Regulation
    Randy J Seeley; Fiscal Year: 2010
    ..upon another cytokine that parallels at least some of these actions of leptin: Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF)...
  6. Roles of GM-CSF in Energy and Glucose Regulation
    Randy Seeley; Fiscal Year: 2007
    ..upon another cytokine that parallels at least some of these actions of leptin: Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF)...
  7. GM-CSF responsiveness in alcohol-mediated lung injury
    David Guidot; Fiscal Year: 2009
    ..lung are normally regulated within the alveolar space by granulocyte-macrophage colony-stimulating factor (GM-CSF)...
  8. HIV-1 and ethanol-induced alveolar epithelial and macrophage dysfunction
    David Guidot; Fiscal Year: 2007
    ..or perhaps as a consequence) ethanol ingestion impairs granulocyte/macrophage colony-stimulating factor (GM-CSF) receptor expression and signaling in alveolar epithelial cells and macrophages, and recombinant GM-CSF restores ..
  9. MECHANISM(S) OF CHEMICAL LEUKEMOGENESIS
    Richard Irons; Fiscal Year: 1993
    ..enhances the colony-forming response of murine HPC to granulocyte/macrophage colony-stimulating factor (rGM-CSF) in culture...
  10. Cytokine Regulation of Dendritic Cell Development
    Stephanie Watowich; Fiscal Year: 2007
    ..Flt3L-dependent pDC development is severely inhibited by granulocyte-macrophage colony- stimulating factor (GM-CSF), which promotes mDC formation at the expense of pDCs...
  11. GM-CSF is required for macrophage surfactant catabolism
    Tracey Bonfield; Fiscal Year: 2006
    ..The granulocyte macrophage-colony stimulating factor (GM-CSF) knockout mouse develops a PAP like syndrome, which can be resolved by pulmonary expression of ..
  12. EOSINOPHIL APOPTOSIS IN ASTHMA
    Gerald Litwack; Fiscal Year: 2001
    ..The cytokines interleukin-3 (IL-3), IL-5, and granulocyte- macrophage colony-stimulating factor (GM-CSF) are important in eosinophil development and activation...
  13. Cytokine Dysregulation in GM-CSF Autoimmunity
    Mary Jane Thomassen; Fiscal Year: 2007
    ..recognized autoimmune disorder characterized by neutralizing autoantibodies to granulocyte-macrophage colony stimulating factor (GMCSF) and severely dysregulated lung surfactant metabolism, the GM-CSh requirement in normal ..
  14. NEUROFIBROMATOSIS TYPE 1 GENE REGULATES MYELOPOIESIS
    DAVID CLAPP; Fiscal Year: 2006
    ..cells is their propensity to hyperproliferate in response to low doses of the growth factor granulocyte macrophage colony stimulating factor (GM-CSF)...
  15. ORAL EPITHELIAL CELL CYTOKINES CANDIDA & PMN ACTIVATION
    Anna Dongari Bagtzoglou; Fiscal Year: 2002
    ..for neutrophil activation of antifungal functions, including interleukin-1 beta (IL-1b) and granulocyte macrophage colony stimulating factor (GM-CSF)...
  16. PROTECTIVE ANTIGENS FROM HISTOPLASMA CAPSULATUM
    GEORGE DEEPE; Fiscal Year: 2007
    ..months and sustaining its durability requires tumor necrosis factor (TNF)-c_ and granulocyte-macrophage colony stimulating factor (GM-CSF) but not interleukins-10 or -12 or interferon-¿...
  17. PROTECTIVE ANTIGENS FROM HISTOPLASMA CAPSULATUM
    GEORGE DEEPE; Fiscal Year: 2006
    ..and sustaining its durability requires tumor necrosis factor (TNF)-alpha and granulocyte-macrophage colony stimulating factor (GM-CSF) but not interleukins-10 or -12 or interferon-gamma...
  18. LIVER LUNG INTERACTIONS DURING GRAM NEGATIVE ENDOTOXEMIA
    George Matuschak; Fiscal Year: 1999
    ..TNF-alpha), interleukin (IL)-1alpha, IL-1beta, IL4, and granulocyte-macrophage colony-stimulating factor (GM-CSF), leading to cardiopulmonary dysfunction and ischemic- hypoxic cellular injury...
  19. The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
    SE TE HUANG; Fiscal Year: 2009
    ..necrosis factor-a (TNF-1) and interleukin-1 beta (IL-12), profoundly enhanced expression of macrophage-colony stimulating factor (M-CSF), granulocyte- macrophage-colony stimulating factor (GM-CSF), which activate immature MFs and DCs ..
  20. The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
    SE TE HUANG; Fiscal Year: 2009
    ..necrosis factor-a (TNF-1) and interleukin-1 beta (IL-12), profoundly enhanced expression of macrophage-colony stimulating factor (M-CSF), granulocyte- macrophage-colony stimulating factor (GM-CSF), which activate immature MFs and DCs ..
  21. Angiogenic tissue engineering to limit post-infarction ventricular remodeling
    Y Joseph Woo; Fiscal Year: 2010
    ..infarction and ventricular remodeling, bone marrow production of EPCs will be stimulated with granulocyte macrophage colony stimulating factor (GMCSF)...
  22. Quercetin Treatment of Airway Inflammation
    MARC HERSHENSON; Fiscal Year: 2006
    ..cell expression of inter- leukin (IL)-8, a neutrophil chemoattractant, and granulocyte macrophage-colony stimulating factor (GM- CSF), an eosinophil chemoattractant, in response to pro-inflammatory stimuli...
  23. The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
    Se Te Joseph Huang; Fiscal Year: 2010
    ..necrosis factor-a (TNF-1) and interleukin-1 beta (IL-12), profoundly enhanced expression of macrophage-colony stimulating factor (M-CSF), granulocyte- macrophage-colony stimulating factor (GM-CSF), which activate immature MFs and DCs ..
  24. The Role of Decidual Innate Immunity in the Pathogenesis of Preeclampsia
    Se Te Joseph Huang; Fiscal Year: 2010
    ..necrosis factor-a (TNF-1) and interleukin-1 beta (IL-12), profoundly enhanced expression of macrophage-colony stimulating factor (M-CSF), granulocyte- macrophage-colony stimulating factor (GM-CSF), which activate immature MFs and DCs ..